Drug
Disodium Clodronate With 1 Lidocaine
Disodium Clodronate With 1 Lidocaine: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| disodium clodronate 200 mg/4 ml with 1% lidocaine NCT01348243 | Phase 3 | Postmenopausal Osteoporosis |
Latest
No recent events.
Follow Disodium Clodronate With 1 Lidocaine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.